Global Genetic Testing Industry Outlook to 2023 with Market Shares by Key Players

News provided by

Aug 28, 2020, 12:30 ET

DUBLIN, Aug. 28, 2020 /PRNewswire/ -- The "The Global Genetic Testing Market By Direct to Consumer, Prenatal, Predictive and Pharmacogenomic including Test Price and Volume Forecasts with Executive and Consultant Guides 2019 to 2023" report has been added to ResearchAndMarkets.com's offering.

Will all newborns receive Whole Genomic Sequencing at birth? What key interest is driving Direct to Consumer?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating a new life for the industry.

The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

Key Topics Covered

1. Introduction and Market Definition
1.1 Genetic Testing Definition in This Report
1.2 The Genomics Revolution
1.3 Market Definition
1.3.1 Volumes
1.3.2 Prices
1.3.3 Revenue Market Size
1.4 U.S. Medical Market and laboratory Testing - Perspective
1.4.1 U.S. Medicare Expenditures for laboratory testing

2. Market Overview
2.1 Market Participants Play Different Roles
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 DTC Lab
2.1.9 Independent Genetic Testing Lab
2.1.10 Audit Body
2.2 Genetic Tests - Types, Examples and Discussion
2.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
2.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
2.2.3 Newborn Screening
2.2.2 Diagnostic Testing
2.2.3 Carrier Testing
2.2.6 Predictive and Presymptomatic Testing
2.2.7 Pharmacogenomics
2.2.8 Forensic Testing
2.2.9 Parental Testing
2.2.10 Ancestral Testing
2.3 Industry Structure
2.3.1 Hospitals Testing Share
2.3.2 Economies of Scale
2.3.2.1 Hospital vs. Central Lab
2.3.3 Physician Office Labs
2.3.4 Physicians and POCT
2.4 Profiles of Key Companies

23andME Inc.
Abbott Diagnostics
Adaptive Biotechnologies
Admera Health, LLC
Agena Bioscience, Inc.
Agilent
Akonni Biosystems
Ancestry.com LLC
Anchor Dx
ArcherDx, Inc.
ARUP Laboratories
Asuragen
Beckman Coulter, Inc.
Becton, Dickinson and Company
BGI Genomics Co. Ltd.
Bioarray Genetics
Biocept, Inc.
Biodesix Inc.
BioFluidica
BioGenex
Biolidics Ltd.
bioMrieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc.
Bio-Techne
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Centogene
Cepheid (now Danaher)
Chronix Biomedical
Circulogene
Clinical Genomics
Complete Genomics, Inc. - A BGI Company
Cynvenio
Dante Labs
Datar Cancer Genetics Limited
Diasorin S.p.A.
Epic Sciences
Epigenomics AG
Eurofins Scientific
Excellerate Bioscience
Exosome Diagnostics
Fabric Genomics
Fluidigm Corp.
Foundation Medicine
Freenome
FUJIFILM Wako Diagnostics
Fujirebio
GE Healthcare Life Sciences
Gene by Gene, Ltd.
Genedrive
GeneFirst Ltd.
Genetron Health (Beijing) Co. Ltd.
Genomic Health
Genomics England
Genomics Personalized Health (GPH)
GenomOncology
Genzyme Corporation
Grail, Inc.
Grifols
Guardant Health
Guardiome
HeiScreen
Helix
Helomics
Hologic
Horizon Discovery
HTG Molecular Diagnostics
Human Longevity, Inc.
iCellate
Illumina
Incell Dx
Inivata
Integrated Diagnostics
Invitae Corporation
Invivoscribe
Karius
MDNA Life SCIENCES, Inc.
MDx Health
Medgenome
Meridian Bioscience
Mesa Biotech
MIODx
miR Scientific
MNG Labs
Molecular MD
NantHealth, Inc.
Natera
NeoGenomics
New Oncology
Novogene Bioinformatics Technology Co. Ltd.
Omega Bioservices
OncoDNA
ORIG3N, Inc.
Origene Technologies
Oxford Nanopore Technologies
Pacific Biosciences
Panagene
Perkin Elmer
Personal Genome Diagnostics
Personalis
Precipio
PrecisionMed
Promega
Protagen Diagnostics
Qiagen GmbH
Quantumdx
Resolution Biosciences, Inc.
Roche Molecular Diagnostics
Seegene
Sequencing.com
Siemens Healthineers
simfo GmbH
Singlera Genomics Inc.
SkylineDx
Stratos Genomics
Sure Genomics, Inc.
Sysmex
Sysmex Inostics
Tempus Labs, Inc.
Thermo Fisher Scientific Inc.
Veritas Genetics
Volition

2.5 Market Shares of Key Genetics Players - Analysis

3. Market Trends
3.1 Factors Driving Growth
3.1.1 Genetic Discoveries Creating New Diagnostic Markets
3.1.2 Aging Population a Boon for Diagnostics
3.1.3 Pharmacogenomics Drives Further Growth
3.1.4 Oncology and Liquid Biopsy Enter New Era
3.1.5 Fertility Practice Growth drives market
3.1.6 Direct to Consumer begins to break out
3.2 Factors Limiting Growth
3.2.1 Increased Competition Lowers Price
3.2.2 Lower Costs
3.2.3 Testing usage analysis curtailing growth
3.2.4 Wellness has a downside
3.3 Instrumentation and Automation
3.3.1 Instruments Key to Market Share
3.3.2 Bioinformatics Plays a Role
3.4 Diagnostic Technology Development
3.4.1 Next Generation Sequencing Fuels a Revolution
3.4.2 Impact of NGS on pricing
3.4.3 POCT/Self Testing Disruptive Force
3.4.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.4.5 CGES Testing, A Brave New World
3.4.6 Biochips/Giant magnetoresistance based assay

4. Genetic Testing Recent Developments
4.1.1 Importance of This Section
4.1.2 How to Use This Section

Arivale Shuts Down Personalized Wellness Business
ArcherDX Acquires Baby Genes
MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay
Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
Invitae Partners to Expand Free Epilepsy Genetic Testing Program
Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
NanoString Technologies Prices $103.5M Common Stock Offering
Canine Consumer Genomics Firm Embark Veterinary Raises $10M
Yourgene Health to Acquire Elucigene
Helix, AdventHealth Partner on Genetic Screening Study
Qiagen, NeuMoDx Ink Partnership, Merger Agreement
Prenetics Acquires DNAFit for $10M
Myriad Genetics to Acquire Counsyl for $375M
Roche inks $2.4B deal to buy out Foundation Medicine
Rapid genome sequencing could revolutionize health care
The future goal in the UK is for every cancer patient to have his or her whole genome sequenced
Human Longevity Launches Whole Genome Product, MassMutual Partnerships
Influence of Whole Genome Sequencing growing
$1500 to sequence newborns in China
Scientists discover new nanoparticle, dubbed exomeres, released by tumours
New DNA tests look for 190 diseases in newborn's genetic code
Cordlife, PlumCare Partner to Offer Genetic Testing Services in Asia
New genetic risk score could help guide screening decisions for prostate cancer
Tele-genetics pilot makes genetic counselling accessible
Digital Genetic Assistant OptraGURU Launches Today From Optra Health
PacBridge Capital Partners Invests C$12M in Contextual Genomics
MDxHealth 2017 Revenues Rise 35 Percent on Prostate Cancer Tests
From DNA To Disease: A Diagnosis Made In Under A Day
A New Tool Uses CRISPR to Uncover Genetic Mutations
Sophia Genetics Gains CE-IVD Mark for Leukemia Assay
Novartis Completes Sale of Genoptix Lab Business
Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
PerkinElmer Launches Clinical Whole Genome Sequencing Services
WGS and AI help clinicians scale precision oncology
Veritas Genetics Buys Curoverse
Dante Labs Partners With Amazon UK for Special 349 Whole Genome Sequencing
Toolbox Genomics Launches Personalized Wellness App in Sequencing.com's Revolutionary App Market
CDC invests in WGS to help states respond to infectious disease threats
IBM Watson impresses in WGS brain tumour analysis
OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia
WGS aids in Salmonella outbreak control
CombiMatrix In Merger Agreement with Invitae to be Acquired for $33 Million in Invitae
Common Stock

5. Country Market Sizes - North America
5.1 United States of America
5.1.1 Prenatal and Newborn Testing - Volumes, Prices, Revenues
5.1.2 Predictive Testing - Volumes, Prices, Revenues
5.1.3 Pharmacogenomic Testing - Volumes, Prices, Revenues
5.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
5.1.5 All Genetic testing - Volumes, Prices, Revenues
5.2 Canada

6. Country Markets - Europe
6.1 France
6.2 Germany
6.3 United Kingdom
6.4 Spain
6.5 Italy
6.6 Russia
6.7 Remainder of Europe and Former Soviet Union

7. Country Markets - Asia-Pacific
7.1 China
7.2 Japan
7.3 South Korea
7.4 India
7.5 Australia
7.6 Rest of Asia-Pacific

8. Country Markets - Latin America, Africa & the Middle East
8.1 Brazil
8.2 Mexico
8.3 Rest of Latin America
8.4 Africa & the Middle East

9. Global Market Summary
9.1 Global Market
9.1.1 Prenatal and Newborn Testing - Volumes, Prices, Revenues
9.1.2 Predictive Testing - Volumes, Prices, Revenues
9.1.3 Pharmacogenomics Testing - Volumes, Prices, Revenues
9.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues
9.1.5 All Genetic testing - Volumes, Prices, Revenues

10. The Future of Genetic Testing

For more information about this report visit https://www.researchandmarkets.com/r/xpytel

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets